Orion OYJ (OTCMKTS:ORINY – Get Free Report) posted its earnings results on Friday. The company reported $0.58 earnings per share (EPS) for the quarter, Zacks reports. Orion OYJ had a return on equity of 49.17% and a net margin of 27.14%.
Orion OYJ Price Performance
ORINY stock opened at $38.54 on Friday. The stock has a market cap of $10.88 billion, a PE ratio of 17.68 and a beta of 0.08. The firm’s 50-day simple moving average is $38.41 and its 200 day simple moving average is $38.72. Orion OYJ has a fifty-two week low of $30.89 and a fifty-two week high of $42.75. The company has a quick ratio of 1.13, a current ratio of 1.77 and a debt-to-equity ratio of 0.10.
About Orion OYJ
Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.
Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.
Further Reading
- Five stocks we like better than Orion OYJ
- J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks
- The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
